Difference in virulence and resistance to pyrazinamide between M. bovis and M. tuberculosis.
van Loenhout-Rooyackers
J H
JH
D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D009163:Mycobacterium bovis / Q000187:drug effects* / Q000472:pathogenicity*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000472:pathogenicity*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents